Evidence map›Paper›PMID 42397474›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Validation of predictive and concurrent validity of global leadership initiative on malnutrition nutritional risk screening using PNI, ALI, and GNRI as alternative tools in patients with cancer.

Lishuang Wei, Jiajun Yang, Shuyao Wang, Nuo Xu, Yibo Chen, Pei Zhong, Siyu Lin, Hanping Shi, Junqiang Chen, Hailun Xie

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lishuang Wei *Department of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Jiajun Yang *Department of Coloretal Surgery, Huizhou Central People's Hospital, Huizhou, China.
Shuyao WangDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Nuo XuDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Yibo ChenDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Pei ZhongDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Siyu LinDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Hanping ShiDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. shihp1@ccmu.edu.cn.
Junqiang ChenDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. chenjunqiang@gxmu.edu.cn.
Hailun XieDepartment of Gastrointestinal and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. hailunxie1@163.com.ORCID https://orcid.org/0009-0001-1770-5651

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the predictive and concurrent validity of Global Leadership Initiative on Malnutrition (GLIM) criteria using prognostic nutritional index (PNI), advanced lung cancer inflammation index (ALI), and geriatric nutritional risk index (GNRI) as alternative screening tools (vs. NRS-2002-based GLIM) for malnutrition in cancer patients.

methodsA total of 11,693 patients with cancer were included in the retrospective cohort study. The Cox/logistic regression analyzed associations of GLIM-defined malnutrition with survival, short-term outcomes, and healthcare burden. Agreement analyses of each nutritional risk-screening tool were performed using kappa statistics and Harrell's concordance-index.

resultsUnder the GLIM framework, all nutrition-related indicators used as nutritional risk screening tools were effective for identifying patients with poor prognosis. Logistic regression showed that the nutrition-related indicator-based GLIM criteria were useful for predicting short-term outcomes, length of stay, and hospital expenses in patients with cancer. Of different GLIM measures, the ALI-based GLIM had the best prognostic discriminative ability, followed by the PNI-based and GNRI-based GLIM, with NRS-2002 ranking the lowest. The prevalence of malnutrition determined using the GLIM criteria based on the NRS-2002, ALI, GNRI, and PNI screening was 29.4%, 25.9%, 26.9%, and 23.3%, respectively. The agreement of the ALI-based, GNRI-based, and PNI-based GLIM with the NRS-2002-based GLIM was 0.550, 0.600, and 0.496, respectively.

conclusionsNutritional indicators can serve as an effective initial step in the GLIM criteria for nutritional risk assessment in patients with cancer, with ALI being the optimal nutritional risk screening tool. Using nutritional indicator-based GLIM criteria is effective for predicting short-term outcomes, medical burden, and long-term prognosis in patients with cancer.

Indexed as

MalnutritionNeoplasmsNutrition AssessmentAdultAgedAged, 80 and overCohort StudiesFemaleHumansLength of StayLogistic ModelsMaleMass ScreeningMiddle AgedNutritional StatusPrognosisCancerGlobal Leadership Initiative on MalnutritionMalnutritionNutritional indicatorsOverall survival

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.